Skip to main content

Advertisement

Recent advances in breast cancer treatment

This special series showcases the advances in our understanding that has driven the substantial progress made in the targeted therapy of breast cancer, bringing together the translational research behind these new approaches as well as reviewing treatments with early evidence of efficacy that are still in clinical development.

Jenny Chang

  1. Review

    Dual HER2 blockade: preclinical and clinical data

    The estrogen receptor and human epidermal growth factor receptor (HER) signaling pathways are the dominant drivers of cell proliferation and survival in the majority of human breast cancers. Not surprisingly, ...

    Tejal A Patel, Bhuvanesh Dave, Angel A Rodriguez, Jenny C Chang, Edith A Perez and Gerardo Colon-Otero

    Breast Cancer Research 2014 16:419

    Published on: 31 July 2014

    The Erratum to this article has been published in Breast Cancer Research 2014 16:468

  2. Review

    Trastuzumab emtansine: mechanisms of action and drug resistance

    Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate that is effective and generally well tolerated when administered as a single agent to treat advanced breast cancer. Efficacy has now been demonstrate...

    Mark Barok, Heikki Joensuu and Jorma Isola

    Breast Cancer Research 2014 16:209

    Published on: 5 March 2014

  3. Review

    Immune approaches to the treatment of breast cancer, around the corner?

    Immunotherapy for the treatment of breast cancer can be categorized as either (a) specific stimulation of the immune system by active immunization, with cancer vaccines, or (b) passive immunization, such as tu...

    Carmen Criscitiello, Angela Esposito, Lucia Gelao, Luca Fumagalli, Marzia Locatelli, Ida Minchella, Laura Adamoli, Aron Goldhirsch and Giuseppe Curigliano

    Breast Cancer Research 2014 16:204

    Published on: 25 February 2014

  4. Review

    Clinical development of mTOR inhibitors in breast cancer

    The mammalian target of rapamycin (mTOR) pathway is a central pathway that regulates mRNA translation, protein synthesis, glucose metabolism, lipid synthesis and autophagy, and is involved in malignant transfo...

    Cecile Vicier, Maria Vittoria Dieci, Monica Arnedos, Suzette Delaloge, Patrice Viens and Fabrice Andre

    Breast Cancer Research 2014 16:203

    Published on: 17 February 2014

Advertisement